This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1977 Mar;66(3):420-1.

doi: 10.1002/jps.2600660326.

beta-Lipoproteins: possible plasma transport proteins for basic drugs

J J Vallner, L Chen

PMID: 191588
DOI: 10.1002/jps.2600660326

beta-Lipoproteins: possible plasma transport proteins for basic drugs

J J Vallner et al. J Pharm Sci. 1977 Mar.

. 1977 Mar;66(3):420-1.

doi: 10.1002/jps.2600660326.

Authors

J J Vallner, L Chen

PMID: 191588
DOI: 10.1002/jps.2600660326

No abstract available

PubMed Disclaimer

Similar articles

[Factors of variation in plasma protein binding of drugs in patients with chronic renal failure].
Riant P, Bree F, Morin D, Barre J, Tillement JP. Riant P, et al. Therapie. 1987 Oct-Dec;42(6):507-10. Therapie. 1987. PMID: 3441893 French. No abstract available.
Benzo(a)pyrene uptake by human plasma lipoproteins in vitro.
Shu HP, Nichols AV. Shu HP, et al. Cancer Res. 1979 Apr;39(4):1224-30. Cancer Res. 1979. PMID: 217532 No abstract available.
Transfer of dehydroepiandrosterone- and pregnenolone-fatty acid esters between human lipoproteins.
Provost PR, Lavallée B, Bélanger A. Provost PR, et al. J Clin Endocrinol Metab. 1997 Jan;82(1):182-7. doi: 10.1210/jcem.82.1.3693. J Clin Endocrinol Metab. 1997. PMID: 8989256
Free drug measurements: methodology and clinical significance.
Kwong TC. Kwong TC. Clin Chim Acta. 1985 Oct 15;151(3):193-216. doi: 10.1016/0009-8981(85)90082-8. Clin Chim Acta. 1985. PMID: 3902293 Review. No abstract available.
The binding of drugs to plasma proteins from patients with poor renal function.
Reidenberg MM. Reidenberg MM. Clin Pharmacokinet. 1976;1(2):121-5. doi: 10.2165/00003088-197601020-00003. Clin Pharmacokinet. 1976. PMID: 797494 Review.

See all similar articles

Cited by

Disease-induced changes in the plasma binding of basic drugs.
Piafsky KM. Piafsky KM. Clin Pharmacokinet. 1980 May-Jun;5(3):246-62. doi: 10.2165/00003088-198005030-00004. Clin Pharmacokinet. 1980. PMID: 6156048 Review.
Diseases and drug protein binding.
Tillement JP, Lhoste F, Giudicelli JF. Tillement JP, et al. Clin Pharmacokinet. 1978 Mar-Apr;3(2):144-54. doi: 10.2165/00003088-197803020-00004. Clin Pharmacokinet. 1978. PMID: 25156 Review.
Methodological aspects of the evaluation of the binding of drugs to plasma and tissue proteins.
Tillement JP, Albengres E, Urien S. Tillement JP, et al. Eur J Drug Metab Pharmacokinet. 1979;4(3):123-7. doi: 10.1007/BF03189413. Eur J Drug Metab Pharmacokinet. 1979. PMID: 393513 Review.
Drug binding in plasma. A summary of recent trends in the study of drug and hormone binding.
Hervé F, Urien S, Albengres E, Duché JC, Tillement JP. Hervé F, et al. Clin Pharmacokinet. 1994 Jan;26(1):44-58. doi: 10.2165/00003088-199426010-00004. Clin Pharmacokinet. 1994. PMID: 8137597 Review.
Plasma protein binding of etidocaine during pregnancy and labour.
Morgan DJ, Koay BB, Paull JD. Morgan DJ, et al. Eur J Clin Pharmacol. 1982;22(5):451-7. doi: 10.1007/BF00542552. Eur J Clin Pharmacol. 1982. PMID: 7117359

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Wiley